Ming Kuang
- Hepatology top 0.5%
- Molecular Biology top 10%
- Epidemiology top 5%
- Surgery top 5%
- Oncology top 5%
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (60 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (30 papers)Liver Disease Diagnosis and Treatment (23 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Ming Kuang
87 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Hepatology 1.7k
- Molecular Biology 896
- Epidemiology 880
- Surgery 686
- Oncology 665
Countries citing papers authored by Ming Kuang
This map shows the geographic impact of Ming Kuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Kuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Kuang more than expected).
Fields of papers citing papers by Ming Kuang
This network shows the impact of papers produced by Ming Kuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Kuang. The network helps show where Ming Kuang may publish in the future.
Co-authorship network of co-authors of Ming Kuang
This figure shows the co-authorship network connecting the top 25 collaborators of Ming Kuang. A scholar is included among the top collaborators of Ming Kuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Kuang. Ming Kuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 8 | |
| 4 | 53 | |
| 5 | 138 | |
| 6 | 111 | |
| 7 | Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)breakdown → | 262 |
| 8 | 22 | |
| 9 | 98 | |
| 10 | 17 | |
| 11 | 4 | |
| 12 | 31 | |
| 13 | 6 | |
| 14 | 11 | |
| 15 | 43 | |
| 16 | 9 | |
| 17 | 9 | |
| 18 | 23 | |
| 19 | 84 | |
| 20 | 105 |
About Ming Kuang
Ming Kuang is a scholar working on Hepatology, Cancer Research and Transplantation, having authored 90 papers that have together received 3.6k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (60 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (30 papers) and Liver Disease Diagnosis and Treatment (23 papers). The work is most often cited by research in Hepatology (1.7k citations), Cancer Research (605 citations) and Epidemiology (880 citations). Ming Kuang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Ming‐De Lu, Xiaoyan Xie, Sui Peng, Lixia Xu, Baogang Peng, Zhenwei Peng, Zuo‐Feng Xu, Guangjian Liu, Guangliang Huang and Hui‐Xiong Xu. Their work appears in journals such as Journal of Clinical Oncology, Molecular Cell and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.